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Nickel is one of the most abundant transition
metals in the earth’s crust (1). It is used in a
variety of industrial processes, e.g., nickel
refinement, nickel-cadmium batteries, and
electroplating (2). These processes, in addi-
tion to the incineration of nickel-containing
wastes and fossil fuels, are responsible for the
majority of nickel aerosols found in both the
workplace and the environment (2). It has
been estimated that the average daily expo-
sure to nickel is between 0.2 and 0.4 µg in
both urban and rural environments (2).
Workplace exposure is considerably higher.
The main route for exposure to nickel
compounds is by inhalation. Indeed, a variety
of epidemiologic studies have indicated a sig-
nificant correlation between the number of
respiratory cancers and workplace nickel expo-
sure (3,4). An effect of nickel compounds in
animal models, through inhalation, injection
or ingestion, is to produce tumors (5–7).
The mechanism by which nickel toxicity
is exerted has been extensively studied
(8–10). Nickel exposure induces several types
of cellular and nuclear damage (8,11,12).
Although nickel is a potent carcinogen, it is
generally not active in mutagenic assays
(13–16). This suggests that nickel-induced
toxicity/carcinogenicity may be caused by
alterations in gene expression rather than by
direct DNA damage. For example, transcrip-
tion factors, metallothionein, and heat shock
proteins can be induced by exposure to
nickel (17–19).
Nuclear factor κ B (NF-κ B) was first
described as a B-cell nuclear factor that binds
to immunoglobulin κ enhancer and thus was
implicated in immune response (20,21).
Subsequent research revealed that NF-κ B was
not B-cell speciﬁc and could bind to speciﬁc
sites in a variety of gene promoter/enhancers,
e.g., interleukin (IL)-2, IL-6, granulocyte
macrophage colony-stimulating factor, inter-
cellular adhesion molecule-1, and class I
major histocompatibility complex (22–24).
Initially the number of inducers of NF-κ B
was quite small but has since grown substan-
tially, e.g., tumor necrosis factor, IL-1, ultra-
violet radiation, growth factors, free radicals,
and viral infection (22–24). Additionally,
there is an increasing body of evidence sug-
gesting a role for NF-κ B in carcinogenesis.
For example, NF-κ B is implicated in signal-
ing tumor promoter-induced transformation
and is activated by viral transforming proteins
(24–26). The importance of NF-κ B cannot
be overstated, as failure in any of the mecha-
nisms leading to NF-κ B activation can have
serious consequences for the cell. Studies
involving NF-κ B are frequently compared
with those involving activator protein-1 (AP-
1). AP-1 is a transcription factor complex
composed of Jun family homodimers or
Jun/Fos heterodimers (27,28). As with NF-
κ B, AP-1 is activated by a number of differ-
ent stimuli, including cell stress, cytokines,
growth factors, and neurotransmitters
(27–29). Both AP-1 and some of the gene
transcripts regulated by AP-1 are involved in
neoplastic transformation (30–33). As a result
we have further investigated the possible
involvement of NF-κ B and AP-1 in nickel-
induced carcinogenesis.
Materials and Methods
Plasmids and Agents
The cytomegalovirus (CMV)-neo vector
plasmid and AP-1-luciferase reporter, as well
as NF-κ B-luciferase reporter plasmids, were
constructed as previously described (34–36).
Anhydrous nickel chloride (NiCl2) was
purchased from Aldrich (Milwaukee, WI,
USA); nickel subsulﬁde (Ni3S2) was obtained
from INCO (Toronto, Canada). Fetal
bovine serum (FBS) was obtained from Life
Technologies, Inc. (Carlsbad, CA, USA).
Eagle’s minimal essential medium (MEM)
and Dulbecco’s modified Eagle’s medium
(DMEM) were both obtained from
BioWhittaker (Walkersville, MD, USA). The
luciferase assay substrate was purchased from
Promega (Madison, WI, USA).
Cell Culture
Mouse ﬁbroblasts 3T3 and B82 cells, as well
as their NF-κ B-luciferase reporter or 
AP-1–luciferase reporter stable transfectants,
were cultured in DMEM with 10% FBS, 2
mM L-glutamine, and 25 µg gentamicin/mL
(34). Human bronchial epithelial cell BEAS-
2B stable transfectants Iκ B kinase β (IKKβ ) or
IKKβ dominant negative mutant (IKKβ -KM)
were cultured in 10% FBS, 2 mM L-gluta-
mine, and 25 µg gentamicin/mL as reported
by Chen et al. (37) and Huang et al. (38).
Generation of Stable Transfectants
with NF-κ B-Luciferase Reporter
or AP-1-Luciferase Reporter
3T3 cells were cultured in a 6-well plate until
they reached 85–90% conﬂuence. CMV-neo
vector (1 µg) and 15 µL LipofectAMINE
reagent, (Gibco BRL, Rockville, MD, USA)
together with 12 µg NF-κ B-luciferase
reporter plasmid DNA or AP-1-luciferease
reporter plasmid DNA, were used to transfect
each well in DMEM in the absence of serum.
After 10–12 hr, the medium was replaced
with 10% FBS DMEM. Approximately
30–36 hr after the beginning of the transfec-
tion, the cells were trypsinized with 0.033%
trypsin, and cell suspensions were plated onto
75-mL culture ﬂasks and cultured for 24–28
days with G418 selection (600 µg/mL).
Measuring basal level of luciferase activity
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identified the stable transfectants. Stable
transfectants 3T3 NF-κ B mass1 or 3T3 AP-1
mass1 were established and cultured in
G418-free MEM for at least two passages
before each experiment.
Assay for NF-κ B Activation
Confluent monolayers of 3T3 NF-κ B
mass1 or IKKβ were trypsinized, and 8 ×
103 viable cells were suspended in 100 µL
culture medium in each well of a 96-well
plate. Plates were incubated at 37°C in a
humidified atmosphere containing 5%
CO2. Twelve to 24 hr later, cells were
starved by culturing them in 0.1% FBS
DMEM for 24 hr. The cells were then
exposed to either Ni3S2 or NiCl2 for NF-κ B
induction and maintained in culture. The
cells were extracted with lysis buffer at vari-
ous times, and luciferase activity was mea-
sured. The results are expressed as relative
NF-κ B activity (35).
Assay for AP-1 Activity
Confluent monolayers of 3T3 AP-1 mass1
or B82 AP-1 mass2 were trypsinized, and
8 ×  103 viable cells suspended in 100 µL
culture medium were added to each well of a
96-well plate. Plates were incubated at 37°C
in a humidified atmosphere containing
5% CO2. Twelve to 24 hr later, cells were
starved by culturing them in 0.1% FBS
DMEM for 24 hr. The cells were then
exposed to either Ni3S2 or NiCl2 for AP-1
induction and maintained in culture. The
cells were extracted with lysis buffer, and
luciferase activity was measured. The results
are expressed as relative AP-1 activity (34).
Statistical Analysis
The significance of the difference in the 
NF-κ B and AP-1 activities was determined
with the Student t test. The results are
expressed as mean ± SEM.
Western Blot Analysis
Human bronchial epithelial cell line BEAS-2B
and its stable transfectant IKKβ -KM were
cultured in each well of 6-well plates to 90%
conﬂuence. The cells were exposed to NiCl2
or Ni3S2 and incubated for different times
indicated in the ﬁgure legends. The cells were
then washed once with ice-cold phosphate-
buffered saline (PBS) and extracted with
sodium dodecyl sulfate (SDS)-sample buffer.
The cell extracts were separated on polyacry-
lamide–SDS gels, transferred, and probed
with one of two antibodies, including rabbit
specific antibody against Cap43 protein or
speciﬁc antibody against protein kinase C α .
The protein bands speciﬁcally bound to pri-
mary antibodies were detected using an anti-
rabbit immunoglobulin G (IgG)–AP-linked
(Amersham Biosciences, Piscataway, NJ,
USA) as second antibody and an ECF
Western blotting system (36).
Results
Effect on Induction of NF-κ B in
Mouse Fibroblast 3T3 Cells 
by Nickel Compounds
To determine the effects of nickel on NF-κ B
activation in mouse fibroblast cells, we
incubated mouse fibroblast 3T3 cells with
either Ni3S2 (2 µg/cm2) or NiCl2 (1 mM) and
monitored the effect on NF-κ B-dependent
transcriptional activation. Shown in Figure 1A
is the relative NF-κ B activity in 3T3 cells after
treatment with either Ni3S2 or NiCl2. It can
be seen that Ni3S2 is a potent activator of NF-
κ B and induces an approximately 12-fold
increase in NF-κ B relative to untreated cells.
NiCl2 treatment also produces an increase in
NF-κ B activity (∼ 6-fold), although not quite
as pronounced as with Ni3S2. Figure 1B
shows the time course for maximal NF-κ B
activation upon Ni3S2 treatment. The results
indicate a gradual increase in relative NF-κ B
activity over a period of 24 hr (5-fold
increase). Activation increases to a maximum
after 48 hr (12-fold) before decreasing again
after 72 hr (3-fold). A dose–response study of
the effect of Ni3S2 treatment indicates that
induction of NF-κ B activity is concentration
dependent, as shown in Figure 1C. The most
effective dose range of Ni3S2 treatment on
3T3 cells was 1.0–2.0 µg/cm2. These results
indicate that NF-κ B is involved in the cellular
response to nickel compounds.
Effect on Induction of NF-κ B in
Human Bronchial Epithelial BEAS-2B
Cells by Nickel Compounds
A variety of epidemiologic studies indicated
that nickel exposure is correlated with an
increase in the incidence of respiratory cancers
(3–7). To understand the involvement of 
NF-κ B activation in the response of the respira-
tory system to nickel compounds, we tested the
effect of Ni3S2 and NiCl2 on NF-κ B activity in
human bronchial epithelial BEAS-2B cells. As
shown in Figure 2A, treatment of cells with
either Ni3S2 or NiCl2 also leads to an increase
in NF-κ B activity. The increase in NF-κ B
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Figure 1. Induction of NF-κ B activity by nickel compounds in mouse ﬁbroblast 3T3 cells. 3T3 NF-κ B mass1cells (8 × 103) were seeded into each well of a 96-well
plate. After being cultured at 37°C overnight, the cells were starved for 12 hr by replacing the medium with 0.1% FBS DMEM. The cells were then treated as fol-
lows: (A) 1 µg/cm2 Ni3S2 or 1 µM NiCl2 for 48 hr. (B) For a time-course study, the cells were exposed to 1 µg/cm2 Ni3S2 for various times as indicated. (C) For a
dose–response study, the cells were exposed to different concentrations of Ni3S2 as indicated for 48 hr. The luciferase activity was then measured and the
results are presented as NF-κ B–dependent transcription activity relative to control. Each bar indicates the mean and standard deviation of four repeat assay
wells. Asterisk (*) indicates a signiﬁcant increase from control (p < 0.05).Environmental Health Perspectives • VOLUME 110 | SUPPLEMENT 5 | OCTOBER 2002 837
activity upon Ni3S2 treatment is approximately
4.5-fold relative to that in the control, whereas
NiCl2 treatment leads to an approximately 2.7-
fold increase in activity. This induction was
also observed in the dose response of NF-κ B
activity to Ni3S2 (Figure 2B). These results,
taken together with the results from 3T3 cells,
indicate that the induction of NF-κ B is
involved in the response of the cell to nickel
compounds.
Absence of Induction of AP-1
Activity with Nickel Compounds
To test whether the response of cells to Ni3S2
and NiCl2 involves AP-1, we also generated
stable AP-1-luciferase 3T3 transfectants. As
shown in Figure 3, treatment of cells with
Ni3S2 or NiCl2 did not show any induction
of AP-1 activity in 3T3 cells, whereas NF-κ B
activation was observed. In contrast, ultra
violet-C (UVC) radiation resulted in
increases in both NF-κ B and AP-1 activity
(Figure 3). These results indicated that NF-
κ B but not AP-1 was involved in the response
of cells to nickel compounds.
To further explore whether the effects of
Ni3S2 and NiCl2 on AP-1 activity are cell
specific, we tested the effect of nickel com-
pounds on AP-1 activity in fibroblast B82
cells. As with the 3T3 cells, treatment of B82
cells with either Ni3S2 or NiCl2 did not lead
to an increase in AP-1 activity (Figure 4).
Again, UVC radiation treatment resulted in
an increase in AP-1, indicating that the
absence of induction of AP-1 transcriptional
activation toward Ni3S2 and NiCl2 treatment
was not cell-type speciﬁc. This was consistent
with our previous ﬁndings in C141 cells (39).
Induction of Cap43 in BEAS-2B
Stable Transfectants
Both Ni3S2 and NiCl2 induce a novel gene,
Cap43, which is also induced by hypoxia and
the calcium ionophore A23187 (40,41).
Recently it was found that Cap43 was
expressed only in cancer cells, not in normal
cells (42). The mechanism by which nickel
acts is not well understood. To determine
whether NF-κ B activation by nickel is
involved in nickel-induced Cap43 expression,
we compared Cap43 expression between
human bronchial epithelial BEAS-2B cells
and their stable transfectant IKKβ -KM cells.
The results showed that an overexpression of
a IKKβ -KM did not affect nickel-induced
Cap43 expression (Figure 5). This suggests
that the signal transduction pathway leading
to NF-κ B activation by nickel compounds
does not involve Cap43 expression by nickel.
Discussion
In this study we investigated the effect of Ni3S2
and NiCl2 on the transcription factor NF-κ B
and AP-1 in various cell culture models. NF-
κ B activation by nickel compounds was found
in mouse ﬁbroblasts (3T3) and human bron-
choepithelial cells (BEAS-2B), whereas nickel
treatment did not induce any activation of AP-
1 in the same cells. Furthermore, NF-κ B acti-
vation by nickel compounds was not required
for Cap43 expression, as overexpression of the
IKKβ -KM had no effect on Cap43 expression.
Our results indicate that both insoluble
Ni3S2 and soluble NiCl2 are effective inducers
of NF-κ B activation in mouse ﬁbroblast 3T3
cells and human bronchoepithelial BEAS-2B
cells. As has been shown previously, insoluble
Ni3S2 appears to be more effective in potenti-
ating a biochemical response than NiCl2 (43).
The effect of Ni3S2 is both time and dose
dependent. The maximum effect on NF-κ B
activation by Ni3S2 takes place after 48-hr
exposure. The most effective dose is 1.0–2.0
µg/cm2, although the lower dose of 0.5 µg/cm2
is still very effective in inducing an increase in
NF-κ B activity. Ni3S2 was toxic to cultured
hamster lung fibroblasts at 0.5 µg/cm2 (15),
whereas in our system cytotoxicity does not
appear to be a factor until after greater than
48-hr exposures and doses above 2.0 µg/cm2.
This observation is supported by data that 
NF-κ B activity would increase relative to that
of the control (Figure 1B). The reason for this
difference may be due to cell-type speciﬁcity.
The results showing that Ni3S2 and NiCl2
potentiate NF-κ B but not AP-1 activity in
different cell culture models were intriguing.
NF-κ B has been the focus of considerable
research since its discovery in 1986 (20, 21).
NF-κ B is a member of the NF-κ B/Rel family
and exists in an inactive form in cells through
formation of a complex with Iκ B (22,44–51).
Phosphorylation of Iκ B leads to ubiquitina-
tion of the cytoplasmic NF-κ B complex and
subsequent degradation of the complex to
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Figure 2. Induction of NF-κ B activity by nickel compounds in human bronchial epithelial BEAS-2B cells.
BEAS-2B IKKβ transformed cells (8 × 103) were seeded into each well of a 96-well plate. After being cul-
tured at 37°C overnight, the cells were starved for 12 hr by replacing the medium with 0.1% FBS DMEM.
The cells were then treated as follows: (A) 1 µg/cm2 Ni3S2 or 1 mM NiCl2 for 36 hr. (B) For a dose–response
study, the cells were exposed to different concentrations of Ni3S2 as indicated for 36 hr. The luciferase
activity was then measured and the results are presented as NF-κ B–dependent transcription activity rela-
tive to control. Each bar indicates the mean and standard deviation of four repeat assay wells. Asterisk (*)
indicates a signiﬁcant increase from control (p < 0.05).
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Figure 3. Nickel compounds induce activation of
NF-κ B, but not AP-1, in 3T3 cells. 3T3 NF-κ B mass1
or AP-1 mass1 (8 × 103) were seeded into each well
of a 96-well plate. After being cultured at 37°C
overnight, the cells were starved for 12 hr by
replacing the medium with 0.1% FBS DMEM. Then
the cells were treated with Ni3S2 (2 µg/cm2), NiCl2
(1 mM), or UVC radiation (30 J/cm2) for 36 hr. The
luciferase activity was then measured and the
results are presented as relative NF-κ B activity or
relative AP-1 activity. Each bar indicates the mean
and standard deviation of four repeat assay wells.
Asterisk (*) indicates a significant increase from
control (p < 0.05).produce the active form of NF-κ B (52–54).
NF-κ B is then translocated to the nucleus
from the cytoplasm, where it induces gene
activation. Considerable evidence has been
presented to implicate NF-κ B activation with
tumor promotion in cell models (23,25,55).
For example, both v-Rel and p52/Lyt-10,
members of the NF-κ B family, and Bcl-3, an
Iκ B family member, are potentially oncogenic
(24). In addition, it was shown separately that
the c-myc oncogene promoter implicated in
Burkitt lymphoma is activated by NF-κ B (56)
and that NF-κ B positively regulates the
expression of the translocated c-myc gene in
Burkitt lymphoma. Additionally, over-
expressed Iκ Bα in 3T3 cells blocked the abil-
ity of ras alleles to induce focus formation,
again suggesting a role for NF-κ B (57).
Furthermore, overexpressed Iκ Bα crossed
with v-Rel transgenic mice induced a delay in
death from leukemia (23).
AP-1 is a transcription factor complex com-
posed of members of the Jun and Fos families
of proteins (27,28). Both AP-1 and NF-κ B are
activated by similar stimuli, including growth
factors, cytokines, and UVC radiation, leading
to altered gene expression (27–29). Like NF-
κ B, AP-1 has been implicated in tumor promo-
tion in different cell models (27,30,31,58–65).
AP-1 activity was also elevated in mouse epider-
mal JB6 cells, indicating various stages of
tumor promotion (59). Furthermore, tumor
promotion could be inhibited by the use of sev-
eral types of AP-1 inhibitors (38,60–63,66).
In light of the important roles that both
NF-κ B and AP-1 play in tumor promotion by
many chemicals, we wished to investigate the
signal transduction pathways involved in the
carcinogenic properties of nickel. The results
indicate that Ni3S2 and NiCl2 specifically
induce NF-κ B activity but not AP-1 activity
in mouse ﬁbroblast 3T3 cells. The speciﬁcity
of Ni3S2 and NiCl2 for NF-κ B activity is fur-
ther supported by the time-course and
dose–response studies, as well as by the obser-
vation that UVC stimulates both NF-κ B and
AP-1 in 3T3 cells. A comparison with ﬁbrob-
last B82 cells also showed that AP-1 activity
was increased by UVC exposure but not by
Ni3S2 or NiCl2.
Cap43 has been reported to be specifi-
cally induced by nickel compounds in a vari-
ety of cell lines (40,41). Although the
function of the Cap43 protein is not well
understood, it does appear to be induced in
response to an increase in intracellular con-
centration of Ca2+ (41). The complete mech-
anism of signal transduction leading to
Cap43 expression has yet to be elucidated,
but it has been shown that nickel induces
HIF-1 and that this, in turn, activates Cap43
transcription (67). Our current investigation
using BEAS-2B and IKKβ -KM indicates that
overexpression of IKKβ -KM did not block
Cap43 induction in response to both Ni3S2
and NiCl2. Our results suggest that induc-
tion of Cap43 does not involve signals arising
from the NF-κ B pathway.
To summarize the results, Ni3S2 and
NiCl2 activate NF-κ B in both mouse ﬁbrob-
last 3T3 cells and human bronchoepithelial
BEAS-2B cells. In addition, AP-1 activity is
unaffected by nickel treatment in mouse
3T3, human bronchoepithelial BEAS-2B,
and mouse C141 cells, which indicates that
the response to nickel must involve a signal
transduction pathway that terminates with
NF-κ B rather than AP-1. Also, NF-κ B acti-
vation by nickel compounds is not required
for Cap43 expression.
REFERENCES AND NOTES
1. Greenwood NN, Earnshaw A. Chemistry of the Elements.
Oxford:Pergamon Press, 1994.
2. Bennett BG. Environmental nickel pathways to man. IARC
Scientific Publication No. 53. Lyon:International Agency
for Research on Cancer, 1984.
3. Shen HM, Zhang QF. Risk assessment of nickel carcino-
genicity and occupational lung cancer. Environ Health
Perspect 102:275–282 (1994).
4. Langard S. Nickel-related cancer in welders. Sci Total
Environ 148:303–309 (1994).
5. Sunderman FW, Donnelly AJ. Studies of nickel carcino-
genesis metastasizing pulmonary tumors in rats induced
by inhalation of nickel carbonyl. Am J Pathol 46:1027–1042
(1965).
6. Ottolenghi AD, Haseman JK, Payne WW, Falk HL,
Macfarland HN. Inhalation studies of nickel sulfide in
pulmonary carcinogenesis of rats. J Natl Cancer Inst
54:1165–1172 (1975).
7. Sunderman FW. Recent research on nickel carcinogenesis.
Environ Health Perspect 40:131–141 (1981).
8. Sunderman FW. Mechanisms of nickel carcinogenesis.
Scand J Work Environ Health 15:1–12 (1989).
9. Costa M. Molecular mechanisms of nickel carcinogenesis.
Annu Rev Pharmacol Toxicol 31:321–337 (1991).
10. Costa M. Molecular mechanisms of nickel carcinogenesis.
838 VOLUME 110 | SUPPLEMENT 5 | OCTOBER 2002 • Environmental Health Perspectives
Metals Toxicity • Huang et al.
C
o
n
t
r
o
l
N
i
3
S
2
 
0
.
5
 
h
r
N
i
3
S
2
 
1
.
5
 
h
r
N
i
3
S
2
 
4
.
5
 
h
r
N
i
3
S
2
 
2
2
 
h
r
N
i
3
S
2
 
2
2
 
h
r
C
o
n
t
r
o
l
N
i
3
S
2
 
0
.
5
 
h
r
N
i
3
S
2
 
1
.
5
 
h
r
N
i
3
S
2
 
4
.
5
 
h
r
N
i
3
S
2
 
9
 
h
r
N
i
3
S
2
 
9
 
h
r
PKC α
CAP 4
BEAS-2B IKKβ -KM A
C
o
n
t
r
o
l
N
i
C
l
2
 
0
.
5
 
h
r
N
i
C
l
2
 
1
.
5
 
h
r
N
i
C
l
2
 
4
.
5
 
h
r
N
i
C
l
2
 
2
2
 
h
r
N
i
C
l
2
 
2
2
 
h
r
C
o
n
t
r
o
l
N
i
C
l
2
 
0
.
5
 
h
r
N
i
C
l
2
 
1
.
5
 
h
r
N
i
C
l
2
 
4
.
5
 
h
r
N
i
C
l
2
 
9
 
h
r
N
i
C
l
2
 
9
 
h
r
PKC α
CAP 4
BEAS-2B IKKβ -KM B
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